| Latest Forum Topics / SingMedical |
 Post Reply
|
|
Impressive growth in last 3 years
|
|||||
|
easywin
Supreme |
18-Dec-2020 12:19
|
||||
|
x 0
x 0 Alert Admin |
Any targeted price?
|
||||
| Useful To Me Not Useful To Me | |||||
|
josephyeo
Elite |
18-Dec-2020 12:03
|
||||
|
x 0
x 0 Alert Admin |
There had been a lot of heavy accumulation in the past weeks/months. Scroll and can see my earlier postings on the accumulations.
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
HungerStrike
Member |
18-Dec-2020 11:50
|
||||
|
x 0
x 0 Alert Admin |
The way its being traded since morning, doesnt seems to be insider trading... more like BB in control... anyway, im vested... no 38 no sell!
|
||||
| Useful To Me Not Useful To Me | |||||
|
Invest1
Elite |
18-Dec-2020 11:44
|
||||
|
x 0
x 0 Alert Admin |
I actually welcome shorts...they also help push up the price.
|
||||
| Useful To Me Not Useful To Me | |||||
|
3DecadesTrader
Veteran |
18-Dec-2020 11:38
|
||||
|
x 0
x 0 Alert Admin |
hoping to see more positive euphoria to practise Short! lolllll
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Invest1
Elite |
18-Dec-2020 11:32
|
||||
|
x 0
x 0 Alert Admin |
Hopefully after lunch halt trading... | ||||
| Useful To Me Not Useful To Me | |||||
|
easywin
Supreme |
18-Dec-2020 11:30
|
||||
|
x 0
x 0 Alert Admin |
More to come | ||||
| Useful To Me Not Useful To Me | |||||
|
Invest1
Elite |
18-Dec-2020 11:27
|
||||
|
x 0
x 0 Alert Admin |
Broken 30...
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Contratrader
Elite |
18-Dec-2020 11:25
|
||||
|
x 0
x 0 Alert Admin |
Power sia!
|
||||
| Useful To Me Not Useful To Me | |||||
|
Invest1
Elite |
18-Dec-2020 11:22
|
||||
|
x 0
x 0 Alert Admin |
Reached
|
||||
| Useful To Me Not Useful To Me | |||||
|
Contratrader
Elite |
18-Dec-2020 11:17
|
||||
|
x 0
x 0 Alert Admin |
Possible to break 30c soon | ||||
| Useful To Me Not Useful To Me | |||||
|
easywin
Supreme |
18-Dec-2020 11:07
|
||||
|
x 0
x 0 Alert Admin |
Possible after lunch trading halt pending for announcement? | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
bishan22
Supreme |
18-Dec-2020 11:07
|
||||
|
x 0
x 0 Alert Admin |
Breakout after a long flat road...some good news which insider knew....
|
||||
| Useful To Me Not Useful To Me | |||||
|
Invest1
Elite |
18-Dec-2020 11:02
|
||||
|
x 0
x 0 Alert Admin |
Very powerful buying strength | ||||
| Useful To Me Not Useful To Me | |||||
|
easywin
Supreme |
18-Dec-2020 10:57
|
||||
|
x 0
x 0 Alert Admin |
Maybe another Hi-p | ||||
| Useful To Me Not Useful To Me | |||||
|
Invest1
Elite |
18-Dec-2020 10:53
|
||||
|
x 0
x 0 Alert Admin |
I think too late for vaccine play. Privatisation or takeover play? | ||||
| Useful To Me Not Useful To Me | |||||
|
Contratrader
Elite |
18-Dec-2020 09:34
|
||||
|
x 0
x 0 Alert Admin |
This stock why so strong today ? Vaccine play ? | ||||
| Useful To Me Not Useful To Me | |||||
|
Northmanz
Member |
10-Dec-2020 16:04
|
||||
|
x 0
x 0 Alert Admin |
Investing.com -- U.K. regulators flag allergic reactions to the Pfizer/Biontech vaccine. DoorDash raises nearly $3.4 billion in a blockbuster IPO and AirBnB is expected to price later. Stocks edge up as politicians continue stimulus dance and the yuan hits new highs despite inflation dipping below zero for the first time in a decade. Here&rsquo s what you need to know in financial markets on Wednesday, December 9th. 1. Pfizer allergic reaction U.K. health regulators warned that people suffering from allergy issues should not take the vaccine developed by Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), after two British healthcare professionals experienced allergic reactions to the drug after being inoculated earlier in the week. Both carers are recovering well, according to an official from the National Health Service for England. The news comes only two days after the U.K. began a mass immunization program using the drug, and a day after the U.S. Food and Drug Administration said it had found no safety issues in an analysis of data from the companies&rsquo stage 3 trial. The FDA is expected to approve the drug for emergency use at a meeting on Thursday. Elsewhere, the U.K. medical journal The Lancet published a peer review of the drug being developed by AstraZeneca (NASDAQ:AZN) and the University of Oxford, confirming it has over an efficacy rate of over 70% - markedly less than the Pfizer/BioNTech and Moderna (NASDAQ:MRNA) drugs, but enough to make it serviceable. Authorities in the United Arab Emirates confirmed that a drug developed by Chinese biotech company Sinopharm has an 86% efficacy rate. |
||||
| Useful To Me Not Useful To Me | |||||
|
Invest1
Elite |
23-Nov-2020 20:03
|
||||
|
x 0
x 0 Alert Admin |
Yes. Accumulation at 25.5 to 26. | ||||
| Useful To Me Not Useful To Me | |||||
|
josephyeo
Elite |
23-Nov-2020 17:02
|
||||
|
x 0
x 0 Alert Admin |
Lots of accumulation in the past weeks | ||||
| Useful To Me Not Useful To Me | |||||